文献速递骨质疏松与钙磷/甲状旁腺

慢性肾脏病中与矿物质代谢特征相关的遗传变异

Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

研究在3027名多民族慢性肾功能不全队列(CRIC)参与者中进行候选单核苷酸变异分析,发现RGS14基因附近的rs4074995与较低的血磷、较低的FGF23及较低的高甲状旁腺功能亢进症患病率相关,CASR基因的rs1801725与较高的血钙相关。RGS14次要等位基因还与肾脏中RGS14基因表达降低相关。

要点

  • rs4074995(RGS14)每携带一个次要等位基因,血磷降低0.09 mg/dL,FGF23降低8.6%。
  • rs1801725(CASR)与血钙升高0.12 mg/dL相关。
  • 高甲状旁腺功能亢进症患病率因rs4074995基因型不同而异(卡方P < .0001)。

核心结论

  • 携带RGS14 rs4074995次要等位基因的CKD参与者血磷、血浆FGF23及高甲状旁腺功能亢进症患病率均较低,且该等位基因与肾脏中RGS14基因表达降低相关。
  • 需要进一步研究来阐明rs4074995在CKD矿物质代谢紊乱发病机制中的作用。

研究设计与样本

  • 在3027名多民族慢性肾功能不全队列(CRIC)参与者中进行候选单核苷酸变异(SNV)分析,以确定SNV与循环矿物质标志物水平的关联。

主要发现

  • 与RGS14和CASR基因相邻或内部的SNV与矿物质代谢物水平相关,最强关联(P < .001)为rs4074995(RGS14)与血磷(每次要等位基因降低0.09 mg/dL)及FGF23(降低8.6%),以及rs1801725(CASR)与血钙(升高0.12 mg/dL)。
  • 高甲状旁腺功能亢进症患病率因rs4074995(RGS14)基因型不同而异(卡方P < .0001)。
  • 观察到RGS14次要等位基因存在种族差异性遗传。
  • 表达数量性状位点(eQTL)分析显示rs4074995与肾小球(P = 1.03 × 10-11)和肾小管(P = 4.0 × 10-4)中RGS14基因表达降低相关。

关键数值与推荐

  • rs4074995(RGS14)每携带一个次要等位基因,血磷降低0.09 mg/dL,FGF23降低8.6%。
  • rs1801725(CASR)与血钙升高0.12 mg/dL相关。
  • 高甲状旁腺功能亢进症患病率因rs4074995基因型不同而异(卡方P < .0001)。
  • rs4074995与肾小球中RGS14表达降低相关(P = 1.03 × 10-11),与肾小管中RGS14表达降低相关(P = 4.0 × 10-4)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究来阐明rs4074995在CKD矿物质代谢紊乱发病机制中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Chronic kidney disease (CKD) causes multiple interrelated disturbances in mineral metabolism. Genetic studies in the general population have identified common genetic variants associated with circulating phosphate, calcium, parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23). OBJECTIVE: In this study we aimed to discover genetic variants associated with circulating mineral markers in CKD. METHODS: We conducted candidate single-nucleotide variation (SNV) analysis in 3027 participants in the multiethnic Chronic Renal Insufficiency Cohort (CRIC) to determine the associations between SNVs and circulating levels of mineral markers. RESULTS: SNVs adjacent to or within genes encoding the regulator of G protein-coupled signaling 14 (RGS14) and the calcium-sensing receptor (CASR) were associated with levels of mineral metabolites. The strongest associations (P < .001) were at rs4074995 (RGS14) for phosphate (0.09 mg/dL lower per minor allele) and FGF23 (8.6% lower), and at rs1801725 (CASR) for calcium (0.12 mg/dL higher). In addition, the prevalence of hyperparathyroidism differed by rs4074995 (RGS14) genotype (chi-square P < .0001). Differential inheritance by race was noted for the minor allele of RGS14. Expression quantitative loci (eQTL) analysis showed that rs4074995 was associated with lower RGS14 gene expression in glomeruli (P = 1.03 × 10-11) and tubules (P = 4.0 × 10-4). CONCLUSION: We evaluated genetic variants associated with mineral metabolism markers in a CKD population. Participants with CKD and the minor allele of rs4074995 (RGS14) had lower phosphorus, lower plasma FGF23, and lower prevalence of hyperparathyroidism. The minor allele of RGS14 was also associated with lower gene expression in the kidney. Further studies are needed to elucidate the effect of rs4074995 on the pathogenesis of disordered mineral metabolism in CKD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Laster ML, Rowan B, Chen HC, et al. Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease. J Clin Endocrinol Metab. 2022. PMID: 35587600. doi:10.1210/clinem/dgac318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。